The 18th Annual EU Pharmaceutical Law Forum
Hotel Bloom
rue Royale 250
Brussels, Belgium
The 18th Annual EU Pharmaceutical Law Forum
Informa Life Sciences
Hotel Bloom

Schedule of Presentations:

Tuesday, May 12, 2009
08:15:00 Registration and Coffee
08:55:00 Chairman’s Introduction
09:00:00 The EU Pharma Sector Inquiry
09:30:00 Impact of the Sector Inquiry on Innovator and Generic Pharma Tony Woodgate
10:00:00 The Implications of the Sector Inquiry Tim Wilsdon
10:30:00 Morning Coffee
11:05:00 Life-Cycle Management & Settlement Strategies Post Sector Inquiry Marleen Van Kerkhove
11:40:00 Discussion on the Wider Implications of the Sector Inquiry Panel Session Gavin , Robert
12:00:00 Lunch
13:30:00 Market Definition and Dominance in Pharmaceutical Markets Matthijs , Visser
14:05:00 Catch Up On Competition Law from the Past 12 Months Cameron Firth
14:40:00 Parallel Trade after GSK Ian Forrester
15:15:00 Parallel Trade/IP – Repackaging Decisions and Implications Nick Beckett,
15:50:00 Afternoon Tea
16:20:00 New The Current European Patent System – A Patentee's Headache? Sally , Shorthose
16:55:00 Where do we stand on the Supplementary Protection Certificates front? Maria , Manley
17:30:00 End of Day One Networking Drinks
Wednesday, May 13, 2009
08:30:00 Morning Coffee
08:55:00 Chairman’s Introduction
09:00:00 Update on the Current Regulatory Framework Ian Dodds Smith
09:30:00 The New Regulatory Pharmaceutical Package Grant H Castle, Yuung Yuung Yap
10:30:00 Morning Coffee
11:10:00 Future Reform of the Clinical Trials Directive LINDA HORTON
11:40:00 Complying with the EU Data Privacy Directive in the Pharmaceutical Sector Tanguy Van Overstraeten
12:10:00 Update on the Paediatric Medicines Regulation Victoria Kitcatt
12:40:00 Lunch
14:00:00 The Advanced Therapies Regulation Ray Cresswell
15:00:00 Regulatory Requirements and Guidelines for Nanomedical Products Geert van Calster
15:30:00 Afternoon Tea
16:00:00 Judicial Review of Marketing Authorisations - Key Principles and Challenges Peter Bogaert
16:30:00 Legal and Regulatory Requirements for Combination & Borderline Products Elisabethann Wright
16:30:00 Health Technology Assessments - Where Does Europe Stand? Clare Sellars
17:00:00 Marketing and Promotion: Ensuring Compliance
17:05:00 End of Day Two
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.